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Poninvasive Diagnosis of Coronary Artery Disease
n Patients With Heart Failure and Systolic
ysfunction of Uncertain Etiology, Using Late
adolinium-Enhanced Cardiovascular Magnetic Resonance
arlos J. Soriano, MD,* Francisco Ridocci, MD, PHD, FESC,* Jordi Estornell, MD,† Javier Jimenez, MD,*
icente Martinez, MD, PHD,† José A. De Velasco, MD, PHD*
alencia, Spain
OBJECTIVES We evaluated the feasibility of using late gadolinium-enhanced (LGE) cardiovascular
magnetic resonance (CMR) to distinguish left ventricular (LV) systolic dysfunction related or
not to coronary artery disease (CAD) in patients with heart failure (HF) but without clinical
suspicion of CAD as the underlying cause.
BACKGROUND In patients with known CAD, LGE-CMR is capable of distinguishing LV systolic
dysfunction related to CAD from dilated cardiomyopathy.
METHODS Seventy-one patients with HF and LV systolic dysfunction, without a previous history of
myocardial infarction, with neither Q waves nor clinical data suggesting CAD, underwent
both LGE-CMR and coronary angiography.
RESULTS Twenty-six patients (37%) had angiographically proven CAD (70% stenosis of a major
epicardial vessel) (angio [] group), and 45 (63%) had unobstructed coronary arteries (angio []
group). Twenty-one patients in the angio () group (21 of 26, 81%) showed subendocardial
and/or transmural enhancement, whereas only 4 (9%) of 45 in the angio () group showed it (p
 0.001). In 7 patients (7 of 71, 10%), we found a different pattern of mid-wall enhancement—
namely, 3 of 26 patients in the angio () group and 4 of 45 in the angio () group (11% vs. 9%,
p  0.7). Mid-wall enhancement in the angio () group was distributed in segments other than
those which had subendocardial enhancement.
CONCLUSIONS In patients with HF and LV systolic dysfunction without clinical suspicion of CAD,
LGE-CMR is an excellent tool for classifying patients in relation to the presence or absence
of underlying CAD. Thus, CMR might offer a valid alternative to coronary angiography for
the detection of CAD in these patients. (J Am Coll Cardiol 2005;45:743–8) © 2005 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.11.037American College of Cardiology Foundation
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woronary artery disease (CAD) constitutes the main cause
f heart failure (HF) with left ventricular (LV) systolic
ysfunction, both in the U.S. (1,2) and Europe (3,4). In
linical practice, patients are classified as having HF of
schemic or nonischemic etiology based on a history of
yocardial infarction (MI) or angiographic evidence of
AD. This differentiation is important because ischemic
tiology has been shown to be independently associated
ith a worse long-term outcome (5–7). In addition, patients
ith ischemic cardiomyopathy may benefit from coronary
evascularization (8) and adequate secondary preventive mea-
ures. According to current practice guidelines, coronary an-
iography should be performed in HF patients with LV
ystolic dysfunction and previous CAD, whether with current
ngina or without it, but having areas of myocardial viability on
oninvasive testing. However, it is unclear how to evaluate HF
atients without a history of CAD who do not produce any
ndings suggesting an underlying ischemic cause (2,9).
Cardiovascular magnetic resonance (CMR) is emerging
s a useful technique for evaluating HF patients, as it allows
From the *Servicio de Cardiología, Consorcio Hospital General Universitario de
alencia, and †Unidad de TC y RM, ERESA, Valencia, Spain.h
Manuscript received July 13, 2004; revised manuscript received October 24, 2004,
ccepted November 1, 2004.precise and noninvasive measurement of LV function and
ood correlation with other cardiac imaging techniques
10–12). Moreover, it may be an aid in diagnosing secondary
auses of heart failure (13–16). Late gadolinium-enhanced
LGE)-CMR is a technique that visualizes both transmural
nd subendocardial scarring caused by a previous MI (17–20),
nd a previous study suggests that enhancement does not
ppear in nonischemic cardiomyopathy (18). In a recent study,
GE has been shown to be a powerful technique to distinguish
V systolic dysfunction related to CAD from dilated cardio-
yopathy (19). In the present study, we evaluated whether
GE can distinguish LV systolic dysfunction related or not to
AD in HF patients without a history of previous MI or
linical data suggesting CAD.
ETHODS
tudy population. The study was approved by our Insti-
utional Medical Ethics Committee, and written, informed
onsent was obtained from all subjects. The study popula-
ion was prospectively enrolled from our cardiology depart-
ent either at hospital admission or during scheduled visits
o our HF clinic. We thus enrolled 71 consecutive patients
ith HF and LV systolic dysfunction but without a previous
istory of MI, Q waves satisfying standard electrocardio-
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Ischemic Cardiomyopathy Diagnosis Using MR March 1, 2005:743–8raphic (ECG) criteria of infarction (21), or clinical data
uggesting CAD (angina or enzymatic criteria of MI [21] or
revious revascularization). All patients had symptoms of HF
nd had echocardiographically documented LV systolic dys-
unction with enlarged end-diastolic LV dimension (95%
ercentile, corrected by height) (22). Patients were excluded if
hey had contraindications to CMR, primary valvular disease,
onstrictive, hypertrophic, or infiltrative cardiomyopathy, or a
istory of myocarditis. All patients underwent coronary an-
iography to determine the presence of obstructive CAD
70% stenosis of a major epicardial vessel). They also under-
ent LGE-CMR. No patient was excluded because of tech-
ical limitations or poor image quality on CMR. Patients were
lassified in two groups based on results from coronary angiog-
aphy: LV systolic dysfunction with obstructive CAD (angio
] group) and LV systolic dysfunction without obstructive
AD (angio [] group).
MR. The CMR images were obtained with a 1.5-T
ystem (Magnetom Sonata; Siemens Medical Solutions,
rlangen, Germany). First, long-axis and short-axis cine
mages of the whole LV myocardium were obtained
sing ECG-gated, steady-state, free-precession pulse se-
uence (8-mm slice thickness with a 3-mm gap between
able 1. Baseline Characteristics of Patients
Characteristic Entire Group
o. of patients (%) 71 (100)
ge (yrs) 57.5  13.3
ender, M/F 58 (82)/13 (18)
MI (kg/m2) 26.1  4.4
YHA score 2.7  0.7
isk factors
Hypertension 31 (44)
Dyslipidemia 24 (34)
Diabetes 16 (22)
Smoker 21 (30)
Ex-smoker 23 (32)
No. of risk factors 1.6  1.1
CG characteristics
Atrial fibrillation 19 (27)
Left bundle branch block 18 (25)
Right bundle branch block 6 (8)
Minor T-wave changes 32 (45)
Poor R-wave progression 25 (35)
Normal ECG 2 ( 1)
Interval CA to CMR (months) 1.9  3.6
Fisher exact test. Data are presented as the number (%) of patients or mean value  S
tudent t test for continuous variables or the chi-square test for categorical variables
Abbreviations and Acronyms
CAD  coronary artery disease
CMR  cardiovascular magnetic resonance
ECG  electrocardiographic
HF  heart failure
LGE  late gadolinium enhancement/enhanced
LV  left ventricle/ventricular
MI  myocardial infarctionBMI  body mass index; CA  coronary angiography; CMR  cardiovascular magnetic
eart Association.hort-axis slices). The LGE images were acquired 10 min
fter intravenous injection (0.1 mmol/kg gadolinium
TPA; Schering AG, Berlin, Germany) with a segmented
nversion-recovery, three-dimensional, turbo-fast, gradient-
cho pulse sequence (repetition time/echo time 500/1.43
s, flip angle 10°, field of view 360 to 400 mm) along 12
hort-axis and long-axis planes (23). The resulting voxel size
as 1.9  1.4  4 mm. The inversion time was adjusted
teratively with different values ranging from 240 to 340 ms
n order to null normal myocardium.
ata analysis. Short-axis cine images were used to calcu-
ate LV volumes and LV ejection fractions by dedicated
nalysis software (Argus; Siemens Medical Solutions). Pre-
iously reported normal CMR ventricular function param-
ters were used as a reference (24,25). A standard 17-
egment cardiac model (26) was used for short-axis slice
egmentation and assessing the extent of LGE. The com-
lete set of short-axis, delayed-enhancement images from the
trioventricular ring to the apex were divided into three groups
or assessing the extent of LGE in basal, mid-cavity, and apical
egments, respectively. The short-axis slices of each group were
egmented following the model (26), and the extent of LGE in
ach segment was assessed blindly to the coronary angio-
raphic results on the following semiquantitative rating scale: 0
no enhancement; 150% or subendocardial; 250%
r transmural. If late enhancement of mid-wall distribution
as found, it was classified in each segment as present or
bsent. The final enhancement score assigned to each segment
f the 17-segment model was simplified by taking into account
nly the maximum score obtained from all the corresponding
egments of the basal, mid-cavity, and apical short-axis slices
roups (usually four for each). The coronary angiogram was
ngio () Group Angio () Group p Value
26 (37) 45 (63) —
62.6  13.3 54.6  12.4 0.01
24 (92)/2 (8) 34 (76)/11 (24) 0.11*
26.0  3.2 26.1  5.0 0.91
2.8  0.6 2.6  0.7 0.35
14 (54) 17 (38) 0.19
13 (50) 11 (24) 0.03
9 (35) 7 (15) 0.06
10 (38) 11 (24) 0.21
8 (31) 15 (33) 0.82
2.0  1.1 1.3  1.1 0.01
6 (23) 13 (29) 0.59
8 (31) 10 (22) 0.42
2 (8) 4 (9) 1*
11 (42) 21 (47) 0.72
10 (38) 15 (33) 0.66
0 2 (1) 0.52*
1.7  3.5 2.0  3.7 0.79
ll p values compare A and B groups. The p values were obtained using the two-tailed
s otherwise indicated). Numbers in boldface indicate p values 0.05.A
D. A
(unlesresonance; ECG  electrocardiographic or electrocardiogram; NYHA  New York
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esults.
tatistical analysis. The distribution of continuous vari-
bles was characterized by reporting the mean value  SD,
hereas the distribution of categorical variables was ex-
ressed as frequencies. Comparisons between groups were
ade, where appropriate, with the two-sample t test for
ontinuous data and chi-square or Fisher exact test for
iscrete data. A level of two-tailed p  0.05 was used to
ndicate statistical significance.
ESULTS
aseline characteristics. Based on angiographic findings,
6 patients (26/71, 37%) showed CAD (angio [] group)
nd 45 did not (45 of 71, 63%) (angio [] group). The
haracteristics of the study population are summarized in
able 1. The angio [] group was younger and with fewer
isk factors than the angio () group. The interval between
ests (angiography to CMR) was similar in both groups.
leven patients in the angio () group (11 of 26, 42%) had
able 2. Cardiovascular Magnetic Resonance Findings: Left Ven
istribution
Characteristic Normal Range
Ent
(
MR LVEDVI (ml/m2) 69  11 1
MR LVESVI (ml/m2) 23  5
MR EF (%) 67  5
nhancement distribution
Subendocardial (50% wall extent) —
Transmural (50% wall extent) —
Subendocardial and/or transmural —
Mid-wall —
ll data are expressed as the number (%) or mean value  SD. Normal ranges are
wo-tailed Student t test for continuous variables or the two-tailed Fisher exact test
CMR  cardiovascular magnetic resonance; EF  ejection fraction; LVEDVI 
eft ventricular end-systolic volume index (indexation to body surface area).
igure 1. A patient with three-vessel coronary artery disease and severe le
ubendocardial and transmural late gadolinium enhancement (LGE) sugges
ransmural LGE pattern in anterior and apical segments in the left anterior de
attern in the basal inferior segment in the right coronary artery territory (wh
id-anterolateral and inferolateral segments affecting the anterolateral papillary mus
rrows). (C) Short-axis apical view showing a transmural LGE pattern in apical anbstructive multivessel disease. Table 2 shows the results of
MR. There were no significant differences in LV param-
ters between groups.
The presence of LGE was significantly higher in patients
ith CAD. Twenty-one patients (21 of 26, 81%) in the
ngio () group had subendocardial and/or transmural
nhancement, whereas only 4 (9%) of 45 patients in the
ngio [] group had subendocardial and/or transmural
nhancement (p  0.001) (Table 2, Figs. 1 and 2). The five
atients in the angio () group who showed no subendo-
ardial or transmural enhancement had obstructive stenosis
n nonproximal segments of the right coronary artery or left
ircumflex coronary artery, but severe LV dysfunction. In 7
atients (7 of 71, 10%), we found a different pattern of
id-wall enhancement; 3 of 26 patients in the angio ()
roup and 4 of 45 in the angio () group (11% vs. 9%, p 
.7) (Table 2) had late enhancement of mid-wall distribu-
ion. All three patients in the angio () group who showed
id-wall enhancement had one-vessel disease. In addition,
n two of three patients in the angio () group, both
ar Functional Parameters and Late Gadolinium Enhancement
roup
1)
Angio () Group
(n  26)
Angio () Group
(n  45) p Value
44 133  31 126  50 0.54
43 101  30 94  49 0.53
10 26  8 28  11 0.37
) 15 (58) 3 (7) <0.0001
) 13 (50) 3 (7) <0.0001
) 21 (81) 4 (9) <0.0001
) 3 (11) 4 (9) 0.70
les. The p values compare A and B groups. The p values were obtained using the
egorical variables. Numbers in boldface indicate p values 0.05.
entricular end-diastolic volume index (indexation to body surface area); LVESVI 
tricular dysfunction (angio [] group), with a multisegmentary pattern of
revious myocardial infarction. (A) Long-axis two-chamber view showing a
ing coronary artery territory (black arrows), as well as a subendocardial LGE
row). (B) Short-axis mid-cavity view showing a transmural LGE pattern intricul
ire G
n  7
29 
97 
27 
18 (25
16 (22
25 (35
7 (10
for ma
for catft ven
ting p
scend
ite arcle, as well as a subendocardial LGE pattern in mid-inferior segment (white
terior and septal segments (white arrows).
p
d
(
D
W
L
p
s
s
d
t
fi
p
C
t
d
s
d
t
n
n
d
d
e
t
n
a
t
d
a
e
t
s
m
w
b
o
e
w
s
T
e
i
d
a
f
o
s
a
a
e
d
s
d
s
l
t
L
t
h
s
s
s
h
p
C
F
c
m
c
s
746 Soriano et al. JACC Vol. 45, No. 5, 2005
Ischemic Cardiomyopathy Diagnosis Using MR March 1, 2005:743–8atterns coexisted, with the mid-wall distribution located in
ifferent segments than the subendocardial enhancement
Fig. 3).
ISCUSSION
e evaluated the capability of LGE-CMR to distinguish
V systolic dysfunction related or not to CAD in HF
atients without a previous history of MI or clinical data
uggesting CAD. We found an overall sensitivity of 81%,
pecificity of 91%, and diagnostic accuracy of 87% in
etermining the presence of obstructive CAD in our pa-
ients using angiography as a diagnostic standard. Our
ndings are consistent with previous studies that evaluated
atients with known CAD (18–20), suggesting that LGE-
MR may be useful in distinguishing LV systolic dysfunc-
igure 2. One patient with severe left ventricular dysfunction without
oronary artery disease (angio [] group) and no late gadolinium enhance-
ent (LGE). (A) Long-axis two-chamber view. (B) Long-axis four-
hamber view. (C) Short-axis mid-cavity view. Note no LGE in the
uppressed myocardium.ion related or not to CAD. As we have shown, this pifferentiation is also feasible in HF patients without clinical
uspicion of CAD as the underlying cause.
In our study, 5 (19%) of 26 patients did not show suben-
ocardial or transmural LGE despite the presence of obstruc-
ive coronary lesions. As patients in our angio () group did
ot have a previous history of MI, the presence of CAD might
ot be associated with myocardial necrosis, thus hindering the
etection of scarred tissue by LGE. Regional ventricular
ysfunction without late enhancement in patients with isch-
mic heart disease has been observed previously (17,18). On
he other hand, the presence of CAD in these patients could
ot be the cause of LV systolic dysfunction, particularly in the
bsence of proximal stenosis of a major coronary artery, and
herefore with little capacity to provoke large areas of myocar-
ial hibernation (27,28). In our study, taking into account
ngiographic data, the sole presence of CAD would not
xplain the severity of LV dysfunction that showed patients in
he angio () group without LGE.
Four (9%) of the 45 patients without coronary artery
tenosis showed a pattern of subendocardial and/or trans-
ural LGE that was indistinguishable from the patients
ith CAD. Similar findings have been reported previously
y McCrohon et al. (19) and Bello et al. (20), with 8 (13%)
f 63 patients and 2 (12%) of 17 patients, respectively. The
xplanation of this finding might be either a previous MI
ithout significant CAD (29,30) or the occurrence of a
ilent MI between the coronary angiogram and CMR.
here is little possibility of the latter in our study, consid-
ring the short time between both tests (1.7  3.5 months
n the angio [] group).
In our study, late mid-wall gadolinium enhancement
istribution was only found in 4 (9%) of 45 patients in the
ngio [] group, and therefore it was a nonsensitive method
or the diagnosis of idiopathic dilated cardiomyopathy. More-
ver, the fact that mid-wall enhancement coexisted with
ubendocardial enhancement in 2 (9%) of 21 patients in the
ngio () group (Fig. 3) suggests that dilated cardiomyopathy
nd CAD can coexist. The pattern of late mid-wall gadolinium
nhancement has been recently described in patients with
ilated cardiomyopathy (19), as well as in other conditions,
uch a hypertrophic cardiomyopathy (31–34) and infiltrative
isease (35,36). The clinical significance of this finding, pre-
umably related to interstitial fibrosis, has not yet been estab-
ished and warrants further investigation.
Late gadolinium enhancement may add useful informa-
ion in two ways to the etiologic classification of HF with
V systolic dysfunction: 1) patients with subendocardial or
ransmural scarring and unobstructed coronary arteries may
ave LV systolic dysfunction due to a silent previous MI, as
uggested by McCrohon et al. (19); and 2) patients without
carring and with one-vessel disease with no proximal
tenosis of a major coronary artery should be considered as
aving nonischemic cardiomyopathy from a diagnostic and
rognostic point of view (7).
linical implications. Coronary angiography is routinely
erformed to exclude the presence of CAD in patients with
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ngina, because perfusion defects and segmental wall mo-
ion abnormalities detected by noninvasive tests suggest
AD, but these signs are frequently also seen in patients
ith nonischemic cardiomyopathy (2). In our group of
atients with LV systolic dysfunction and a low probability
f CAD, the detection of LGE with CMR was a powerful
iagnostic tool for classifying the underlying cause of
ardiomyopathy. In our experience, it improved information
btained from angiographic data that may have important
rognostic and therapeutic implications. In particular, as the
bsence of LGE excludes the presence of infarction or
evere CAD, it may be unnecessary to perform diagnostic
oronary angiography routinely in this setting.
tudy limitations. It can be argued that large areas of
ibernating myocardium without necrosis can lead to severe
igure 3. Two patients with significant one-vessel disease (angio [] grou
adolinium enhancement (LGE) patterns. Patient #1 (A, B, and C) and
id-wall LGE distribution enhancement in the basal anterolateral segmen
nferior segments and with transmural LGE in the apex segment (black a
n the basal anterolateral segment (white arrow) and subendocardial LGE
ubendocardial LGE in the apical inferior segment and transmural LG
id-cavity view of another patient showing longitudinal striae of mid-wa
rrows) coexisting with transmural LGE in the mid-inferior segment (blaschemic LV systolic dysfunction without showing LGE n27,28). However, this scenario is very uncommon, partic-
larly if there is no clinical angina. Indeed, no patient in our
tudy presented with this condition. On the other hand,
ther forms of nonischemic heart disease can cause LGE
13,16,31–36). Nevertheless, the prevalence of these other
isorders is rather low compared with CAD, and their
linical presentation is often different and leads to a correct
iagnosis.
onclusions. Late gadolinium enhancement using CMR
s a useful tool for classifying patients with HF and LV
ystolic dysfunction in relation to the presence or absence of
nderlying CAD. It improves on the information obtained
rom angiographic data. In our patients with HF and LV
ystolic dysfunction but without clinical suspicion of CAD,
GE-CMR allowed us to rule out the presence of signifi-
ant CAD. Thus, this technique may become a valid
wing coexistence of subendocardial and/or transmural with mid-wall late
nt #2 (D). (A) Long-axis two-chamber view showing one patchy foci of
te arrow) coexisting with subendocardial LGE in basal inferior and apical
). (B) Short-axis basal view showing patchy foci of mid-wall distribution
basal inferior segment (black arrow). (C) Short-axis apical view showing
apical septal and apical lateral segments (white arrow). (D) Short-axis
ribution LGE in mid-anteroseptal and mid-inferoseptal segments (white
row).p) sho
Patie
t (whi
rrows
in the
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ck aroninvasive imaging alternative to coronary angiography.
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